KPNA2介导MYC核输入增强CAR-T细胞记忆与抗肿瘤效力
该研究在临床CAR-T细胞产物中发现KPNA2表达与MYC通路激活同更优疗效相关,并证实KPNA2通过促进MYC核输入增强CAR-T细胞记忆形成与抗肿瘤功能。研究还通过虚拟药物筛选发现小分子TMS可增强KPNA2-MYC相互作用,在临床前模型中提升CAR-T抗肿瘤效力。
要点
- KPNA2表达及MYC通路激活与临床CAR-T产物更优治疗效力相关。
- 过表达MYC因核输入不足对CAR-T功能影响甚微,而加入KPNA2促进MYC核输入可增强记忆与抗肿瘤活性。
- 小分子TMS增强KPNA2-MYC相互作用,提升CAR-T记忆表型与抗肿瘤效力。
核心结论
- KPNA2-MYC相互作用是调控CAR-T细胞记忆形成的关键机制,并提供遗传与药理策略优化治疗性T细胞设计与制备。
研究设计与样本
- 研究结合临床CAR-T细胞产物分析与体外、体内功能实验,并采用整合转录组与表观基因组分析及虚拟药物筛选。
主要发现
- 临床CAR-T细胞产物中KPNA2表达和MYC通路激活与更优治疗效力相关。
- 过表达MYC因核输入不足对CAR-T功能影响甚微;加入KPNA2促进MYC核输入,增强记忆形成、细胞毒性与体内外抗肿瘤活性。
- KPNA2过表达CAR-T细胞的功能改善未伴随转化风险。
- KPNA2增加MYC在记忆相关基因位点的占据,上调T细胞记忆程序。
- 虚拟筛选发现小分子TMS增强KPNA2-MYC相互作用,提升MYC核积累、记忆导向转录谱与临床前模型抗肿瘤效力。
临床怎么用
- 可将KPNA2表达与MYC通路激活作为评估临床CAR-T产物效力的候选标志。
- 可通过基因工程引入KPNA2或药理手段(如TMS)增强KPNA2-MYC相互作用以促进CAR-T记忆形成。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Chimeric antigen receptor (CAR)-T cell therapy demonstrates remarkable clinical efficacy, yet limited persistence and functional exhaustion impede durable responses. While memory-like phenotypes are associated with sustained CAR-T function and improved clinical outcomes, the underlying molecular mechanisms of CAR-T cell memory maintenance remain incompletely defined and we still lack actionable strategy to sufficiently promote CAR-T cell memory formation. Here, we identified that Karyopherin Subunit Alpha 2 (KPNA2)-mediated MYC nuclear import robustly enhanced CAR-T cell memory and antitumor function. In clinical CAR-T cell products, KPNA2 expression and MYC pathway activation are correlated with superior therapeutic potency. Overexpressing MYC showed negligible effect on CAR-T cell function due to insufficient nuclear import; in contrast, incorporating KPNA2 in CAR-T cells facilitated MYC nuclear import, augmented memory formation, enhanced cytotoxicity and antitumor activity both in vitro and in vivo. Such functional improvement was not associated with risks of transformation in KPNA2-overexpressing CAR-T cells. Mechanistically, our integrated transcriptomic and epigenomic analyses revealed that KPNA2 increased MYC occupancy at memory-associated gene loci, upregulating T cell memory programs. Furthermore, virtual drug screening identified the small molecule TMS which potentiates KPNA2-MYC interaction. TMS treatment of CAR-T cells enhanced MYC nuclear accumulation, promoted memory-oriented transcriptional profiles, and improved antitumor potency in preclinical models. These findings established KPNA2-MYC interaction as a pivotal mechanism governing CAR-T cell memory formation, providing genetic and pharmacological strategies to advance therapeutic T cell design and manufacturing.
引用
- Han S, Kong D, Yang C, et al. KPNA2-Mediated MYC Nuclear Import Enhances CAR-T Cell Memory and Potentiates Antitumor Efficacy. Blood. 2026. PMID: 42848851. doi:10.1182/blood.2026034296
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。